XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Document and Entity Information - shares
 3 Months Ended
Mar. 31, 2023
May 08, 2023
Document Type 10-Q  
Entity Central Index Key 0001534248  
Document Period End Date Mar. 31, 2023  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 001-38807  
Entity Registrant Name Chemomab Therapeutics Ltd.  
Entity Incorporation, State or Country Code L3  
Entity Tax Identification Number 81-3676773  
Entity Address, Address Line One Kiryat Atidim  
Entity Address, Address Line Two Building 7  
Entity Address, City or Town Tel Aviv  
Entity Address, Postal Zip Code 6158002  
Entity Address, Country IL  
City Area Code 972  
Local Phone Number 77-331-0156  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   11,049,812
American Depositary Shares [Member]    
Title of 12(b) Security American Depositary Shares, each representing twenty (20)  
Trading Symbol CMMB  
Name of Exchange on which Security is Registered NASDAQ  
Ordinary Shares, No Par Value Per Share [Member]    
Title of 12(b) Security Ordinary shares, no par value per share  
Trading Symbol n/a  
Name of Exchange on which Security is Registered NASDAQ